tVNS and Approach-Avoidance Behavior in Anhedonia and Anxiety
Key facts
- Who runs it
- Dr. Nils B. Kroemer
- Where
- Germany1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 104 people, planned
- Started
- 23 Mar 2026
- Expected to end
- 31 Dec 2028
- Type of study
- Interventional, 4 groups
- Treatments tested
- tVNS
- Sham
- Record updated
- 23 April 2026
Who can take part
- Age
- 18 years to 40 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- BMI between 18,5 and 30,0 kg/m2,
- between 18 and 40 years of age, and
- be able and willing to provide informed consent
Who cannot take part
- take medication (except psychopharmacological medication for MDD or anxiety), patients have to be on stable psychopharmacological medication for at least two months before study participation (minimizing confounding effects)
- contraindications for MRI (metal implants or claustrophobia)
- have a lifetime diagnosis of severe neurological disorder (incl. ADHD), schizophrenia, bipolar disorder, or severe substance abuse, posttraumatic stress disorder, obsessive-compulsive disorder, diabetes, epilepsy, or coronary heart disease
- have fulfilled criteria for an eating disorder or somatic symptom disorder within the last 12-months,
- have a high risk of suicide,
- for female individuals if they are pregnant or nursing at the time,
- impaired movement ability or hearing
- impaired, uncorrected vision (need contact lenses)
- contraindications for tVNS hearing aids or diseased skin on the right ear
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 40 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study investigates if anhedonia and anxiety symptoms are associated with alterations in reinforcement learning, effort trade-offs for wins vs. punishments, and foraging behavior under threat. Moreover, it will investigate whether these processes can be influenced by a metabolic load and/or transcutaneous vagus nerve stimulation (tVNS). The project consists of (a) an online reinforcement learning study, used to characterize learning, reward sensitivity, and meta-cognition, and (b) a laboratory study in which participants first undergo fMRI while completing an effort-based decision-making task. Second, participants will complete two sessions in VR with randomized active or sham tVNS during a foraging task before and after a caloric load with concurrent physiological recordings.
The 4 groups in the trial
- Healthy ControlsTreatment being tested
The healthy control group will include participants without clinically relevant symptoms of anxiety or anhedonia. Inclusion criteria are a STICSA total score \<= 40 and a SHAPS total score below 23.5. Participants in this group must not meet the criteria for a current psychiatric diagnosis defined in the exclusion criteria, as confirmed by the Structured Clinical Interview for DSM (SCID).
Treatment: tVNS and Sham
- AnxietyTreatment being tested
The anxiety group will include participants with elevated anxiety symptoms, defined as a STICSA total score \>= 43. All participants must meet diagnostic criteria for a current anxiety disorder or/and current depressive disorder, confirmed by the SCID.
Treatment: tVNS and Sham
- AnhedoniaTreatment being tested
The anhedonia group will include participants with elevated anhedonia symptoms, defined as a SHAPS total score greater than 29.5. All participants must meet diagnostic criteria for a current depressive disorder or/and current anxiety disorder, confirmed by the SCID.
Treatment: tVNS and Sham
- Comorbid anhedonia and anxietyTreatment being tested
The combined group will include participants with both elevated anxiety and anhedonia symptoms, defined as STICSA \>= 43 and SHAPS \> 29.5, respectively. All participants must meet diagnostic criteria for a current anxiety disorder or/and a current depressive disorder, confirmed by the SCID.
Treatment: tVNS and Sham
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Vagus Nerve Stimulation and Approach-Avoidance Behavior in Anhedonia and Anxiety
- Criteria questions
- Built from NCT07476469, who can take part
- Record updated
- 23 April 2026